UK-based Glide Technologies, which develops pharmaceuticals and medical devices, completed a £3.2 million funding round. Investors include Invesco Perpetual, Oxford Technology Venture Capital Trusts, Oxford Capital Partners and Hygea VCT participated.
The company’s develops pharmaceutical products which it delivers with its proprietary needle-free injector, the Glide SDI®.
Read more: FinSMEs
Would you like to write the first comment?
Login to post comments